Home Tags MannKind Corporation (NASDAQ:MNKD)

Tag: MannKind Corporation (NASDAQ:MNKD)

Mannkind Corporation (NASDAQ: MNKD) Announces FDA’s Approval for Tyvaso DPI

Gavins Felicity - 0

NRx Pharmaceuticals (NASDAQ: NRXP) and MannKind Corporation (NASDAQ: MNKD) Enter Agreement...

Ward Sport - 0

Mannkind Corporation (NASDAQ:MNKD) Enters Agreement With Vertice Pharma for Co-Promotion of...

Matt Wade - 0

MannKind Corporation (NASDAQ:MNKD) Reports 27% YoY Growth In Afrezza Revenue In...

Kate Hudson - 0

MannKind Corporation (NASDAQ:MNKD) Posts Revenues Of $15.1 Million In Q2 2020

Ward Sport - 0
12Page 1 of 2

Recent Post

Pfizer’s (NYSE: PFE) Ponsegromab Shows Promise in Fighting Cancer Cachexia

Gavins Felicity - 0
Pfizer (NYSE: PFE) recently announced positive results from a midstage trial of their experimental drug, ponsegromab, designed to treat cancer cachexia, a...

Singular Genomics (OMIC) Receives Buyout Offer, Stock Soars

Instil Bio (TIL) Surges on Promising Cancer Therapy Licensing Deal

Summit Therapeutics Secures $235 Million in Funding from Leading Biotech Investors

Monopar Therapeutics’ (MNPR) MNPR-101-Zr Shows Promising Tumor Targeting in Early Clinical...

© BioPharma Journal 2020